← Leaderboards
Balasubramani K Goundappa
University Of Pittsburgh At Pittsburgh
$8,538,627
Attributed
$17,077,254
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.2M · FY2020–24$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,077,254 · 1
By mechanism
UG1$17,077,254 · 1
Top collaborators
- Stephen R Wisniewski5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Stephen R Wisniewski$41,152,197
- Ian A Sigal$7,257,284
- Gadi Wollstein$5,521,866
- Zhaoyang You$2,731,696
- Thomas R Friberg$649,894
Others in their field
Other Emerging Leaders on “High Risk”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ted Ross · University Of Georgia$70,992,558
- Yunda Huang · Fred Hutchinson Cancer Center$69,424,989
- Bambra Strokes · Ppd Development Lp$65,000,267
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
High RiskArgonAqueousAdherenceCellsClinical ResearchComparative EfficacyComplexCell PhysiologyCorneaData SetDesignDisorder ControlDoseDropsEffectivenessFaceFailureFollow-UpFreedomFree WillGlaucomaGlaucoma SurgeryImpairment
Grant awards (5)
Clarifying the Optimal Application of SLT Therapy (COAST) Trial$7,182,740
UG1 · FY2024 · EY
Clarifying the Optimal Application of SLT Therapy (COAST) Trial$2,769,231
UG1 · FY2023 · EY
Clarifying the Optimal Application of SLT Therapy (COAST) Trial$2,679,188
UG1 · FY2022 · EY
Clarifying the Optimal Application of SLT Therapy (COAST) Trial$2,657,465
UG1 · FY2021 · EY
Clarifying the Optimal Application of SLT Therapy (COAST) Trial$1,788,630
UG1 · FY2020 · EY